CD80 and cancer: Interestingly, our results showed that CD80 was significantly downregulated in several cancer types including LUAD (lung adenocarcinoma), LUSC (lung squamous cell carcinoma), and THCA (thyroid cancer); these results suggest that the role of CD80 might be varied by cancer types.